Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;7(2):97-102.
doi: 10.1111/j.1742-481X.2010.00660.x.

Cost-of-illness of chronic leg ulcers in Germany

Affiliations

Cost-of-illness of chronic leg ulcers in Germany

Sandra Purwins et al. Int Wound J. 2010 Apr.

Abstract

Chronic wounds are important because of their frequency, their chronicity and high costs of treatment. However, there are few primary data on the cost-of-illness in Germany. The aim was to determine the cost-of-illness of venous leg ulcers (VLU) in Germany. Prospective cost-of-illness study was performed in 23 specialised wound centres throughout Germany. Direct, medical, non medical and indirect costs to the patient, statutory health insurers and society were documented. Thereover, health-related quality of life (QoL) was recorded as intangible costs using the Freiburg quality of life assessment for wounds (FLQA-w, Augustin). A total of 218 patients (62.1% female) were recruited consecutively. Mean age was 69.8 +/- 12.0 years. The mean total cost of the ulcer per year and patient was 9569 euros, [8658.10 euros (92%) direct and 911.20 euros (8%) indirect costs]. Of the direct costs, 7630.70 euros was accounted for by the statutory health insurance and 1027.40 euros by the patient. Major cost factors were inpatient costs, outpatient care and non drug treatments. QoL was strikingly reduced in most patients. In Germany, VLU are associated with high direct and indirect costs. As a consequence, there is a need for early and qualified disease management. Deeper-going cost-of-illness-studies and cost-benefit analyses are necessary if management of chronic wounds is to be improved.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Geographic distribution of the participating wound centres (n = 23).

References

    1. Pelka R. The economic situation of chronic wounds. Krankenpfl J 1997;35:338 (German). - PubMed
    1. Augustin M, Siegel A, Heuser A, Vanscheidt W. Chronic leg ulcer: cost evaluation of two treatment strategies. J Dermatol Treat 1999;10 (Suppl. 1):S21–5.
    1. BGBI . Sozialgesetzbuch – Gesetzliche Krankenversicherung: BGBI, Fünftes Buch, Artikel 1 des Gesetzes vom 20. Dezember 1988. BGBI. I S. 2477, das durch Artikel 1 des Gesetzes vom 30. Juli 2009 (BGBI. I S. 2495) geändert worden ist. Available from: http://bundesrecht.juris.de/sgb_5/BJNR024820988.html (German). last visit: 22.09. 2008.
    1. Kassenärztliche Bundesvereinigung [Internet] . 2009. Ärztliche Kooperationen. Integrierte Versorgung. Vertragspartner. Berlin: Kassenärztliche Bundesvereinigung, 2007 Nov 19 [cited 2008 Nov 27]; [about 1 screen]. Available from: http://www.kbv.de/koop/8801.html (German). last visit: 22.09.2009.
    1. Bundesversicherungsamt (DE) . Zulassung der Disease Management Programme (DMP) durch das Bundesversicherungsamt (BVA). Bonn: Bundesversicherungsamt, 2009. (German). Available from: http://www.bundesversicherungsamt.de/nn_1046154/DE/DMP/dmp_node.html?_nn..., last visit: 22.09.2009.